Printer Friendly
The Free Library
14,537,783 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for ALTANA AG.


ALTANA This article is about the corporation. For the village, see Alţâna.

Altana AG (ISIN: DE0007600801) is a German chemical company based in Bad Homburg.

In 2003, Altana had 10,800 employees and a turnover of € 2.7 billion.
 AG is an international pharmaceuticals and chemicals Group with sales of EUR EUR

In currencies, this is the abbreviation for the Euro.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 2.7 billion in 2003 and about 11,000 employees all over the world. We are one of Europe's most profitable pharmaceuticals and chemicals companies, with a return on sales Return on sales

A measurement of operational efficiency equalingnet pre-tax profits divided by net sales expressed as a percentage.


return on sales

The portion of each dollar of sales that a firm is able to turn into income.
 of more than 20%. The ALTANA Group is composed of the strategic management holding company, ALTANA AG, and two operating divisions, ALTANA Pharma Pharma may be an abbreviation for:
  • Pharmaceutical company
  • Pharmaceutical drug
  • Pharmacology
  • Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Pharma (record label)
 AG and ALTANA Chemie AG. This structure enhances the flexibility of the individual divisions and enables targeted development.
Company:                ALTANA AG

Headquarters Address:   Am Pilgerrain 15
                        61352 Bad Homburg
                        Germany

Main Telephone:         +49 (0) 6172 1712 155

Website:                www.altana.com

Ticker:                 AAA(NYSE);ALT(FWB)

Type of Organization:   Public

Industry:               Pharmaceuticals and Chemicals

Earnings Release Dates: 3rd Quarter: November 4, 2004
                        4th Quarter: March 17, 2005


Key Executives:         CEO: Nikolaus Schweickart
                        CFO: Hermann Kuellmer

Corporate Communications
Contact:                Thomas Gauly
Phone:                  +49 (0)6172/ 1712 -150
Email:                  thomas.gauly@altana.de

Media Relations
Contact:                Steffen Mueller
Phone:                  +49 (0)6172/ 1712 -160
Email:                  steffen.mueller@altana.de

Investor Relations
Contact:                Sandra Fabian
Phone:                  +49 (0)6172/ 1712 -163
Email:                  sandra.fabian@altana.de

Investor Relations Contact USA
Contact:                Claudia Diller (Assistant)
Phone:                  +1/ 212/ 974 6192
Email:                  claudia.diller@altana.de

COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 27, 2004
Words:207
Previous Article:Company Profile for Makino Milling Machine Co., Ltd.
Next Article:Company Profile for Vivascience AG.



Related Articles
GPC BIOTECH GETS GERMANY PERMITS FOR MONOCLONAL ANTIBODY.
160,000 SF in new leases closed at Florham Park.(New Jersey)(Brief Article)
DXS AND SANGTEC SIGN SCORPIONS TECHNOLOGY LICENSE PACT.
GBC BIOTECH PRESENTS NEW DATA ON EFFICACY OF SATRAPLATIN.
GPC BIOTECH GETS U.S. PATENT FOR ANTI-CANCER CELL INHIBITOR.
GPC BIOTECH/DEBIOPHARM SIGN MHC II ANTAGONISTS LICENSE PACT.
METACORE PROVIDES MANUALLY CURATED HUMAN DATA BY PHD'S.
GPC BIOTECH PRESENTS NEW SATRAPLATIN DATA AT AACR.
Altana Chemie signs agreement to acquire Eckart.(Business & Industry)
Germans re-think triple-digit rents and sub-lease pricey digs.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles